ImmunoGen
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.21 | -100% | -21.76 | -100% |
| P/S |
|
10.87 | 33.44 | -67.5% |
|
|
| P/BV |
|
7.58 | 4.65 | 63.2% |
|
|
| P/FCF |
|
-19.47 | 42.56 | -145.75% |
|
|
| Ev/Ebitda |
|
-4.24 | -17.68 | -76.02% |
|
|
| Ev/S |
|
3.21 | 22.52 | -85.77% |
|
|
| Ev/FCF |
|
-4.62 | 47.58 | -109.7% |
|
|
| E/P |
|
-0.0189 | 0.0188 | -200.52% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-75.62 | -13.3 | 468.59% | -133.35 | -43.29% |
| ROE |
|
-92.61 | 9.69 | -1055.75% |
|
|
| ROA |
|
-50.97 | 0.2896 | -17700.8% |
|
|
| ROIC |
|
-54.18 | 7.63 | -809.69% |
|
|
| ROS |
|
-25.56 | -25.08 | 1.93% |
|
|
| ROCE |
|
-141.78 | 14.58 | -1072.76% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0699 | -3.62 | -98.07% | -0.0857 | -18.47% |
| Nеt Debt/Ebitda |
|
1.19 | -4.05 | -129.5% |
|
|
| Debt/Ratio |
|
0.0436 | 0.1841 | -76.34% |
|
|
| Debt/Equity |
|
0.7379 | 1.6 | -53.77% |
|
|
| Debt/Net Income |
|
-0.2067 | 0.9168 | -122.55% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
249.47 | 31.71 | 686.72% | ||
| Growth impulse Ebitda in 5 years |
|
259.06 | -23.28 | -1212.8% | ||
| Growth impulse Net Income in 5 years |
|
-39.49 | -61.56 | -35.85% | ||
| Growth impulse FCF in 5 years |
|
119.05 | -26 | -557.88% | ||
| Growth impulse EPS in 5 years |
|
13.45 | -63.63 | -121.14% |
IP Score
3.89/10
